| Name |
Hyaluronidase (JAN/INN);Amphadase (TN) |
| Product |
AMPHADASE (Amphastar Pharmaceuticals) |
| Remark |
ATC code: B06AA03Chemical structure group: DG00190Product (DG00190): D04455<US> D04456 D06604<US> Product (mixture): D11967<JP/US> |
| Efficacy |
Adjuvant (spreading) |
| Comment |
Hyaluronidase [KO:K01197] [EC:3.2.1.35] |
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] B BLOOD AND BLOOD FORMING ORGANS B06 OTHER HEMATOLOGICAL AGENTS B06A OTHER HEMATOLOGICAL AGENTS B06AA Enzymes B06AA03 Hyaluronidase D04456 Hyaluronidase (JAN/INN) New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D04456New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D04456 |
| Other DBs |
CAS: 9001-54-1PubChem: 47206321NIKKAJI: J209.195J |
| LinkDB |
|